AzTrials
AzTrials

Nurse's RoleNCT05637736

Effects of an Immersive Virtual Reality Intervention

A study testing Mindfulness-based Stress Reduction by Therapeutic VR and Mindfulness-based Stress Reduction in people with Nurse's Role and COVID-19 Pandemic, run by Nanjing University of Traditional Chinese Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Some recent studies demonstrated caregivers may experience negative emotions such as anxiety and sadness, which may also affect normal treatment during the epidemic. As the pandemic continues, mental health support, encouragement , and a sense of purpose are needed to support healthcare workers. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Nurse's Role, COVID-19 Pandemic, Mental Stress
What is being tested?
Mindfulness-based Stress Reduction by Therapeutic VR and Mindfulness-based Stress Reduction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteChina
Study dates
1 Mar 2022to 30 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Registered nurses (RN) who work in target departments were included. The target departments mainly included internal medicine, surgical, emergency department, where nurses had direct mutual engagement with patients.

Who cannot join

  • Nurses who have not been involved in the COVID-19 volunteer service.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Wu Ye

    Nanjing, Jiangsu, 210029

Other trials in China

About this study

Official title: Effects of an Immersive Virtual Reality Intervention Combined With Mindfulness-based Therapy on Mental Health in Nurses During the COVID-19 Pandemic: A Randomized Controlled Trial

Some recent studies demonstrated caregivers may experience negative emotions such as anxiety and sadness, which may also affect normal treatment during the epidemic. As the pandemic continues, mental health support, encouragement , and a sense of purpose are needed to support healthcare workers.

Being tested
Mindfulness-based Stress Reduction by Therapeutic VR, Mindfulness-based Stress Reduction
Medical subject headings
COVID-19, Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-based Stress Reduction by Therapeutic VRBehavioural

    Therapeutic VR+MBT was provided using a head-mounted display which designed to enclose eyes and block external stimuli almost entirely. Patients can see immersive natural scenes through VR devices and hear stereo sounds through headphones. We uploaded a programme, which was designed to induce recordings of guided meditations (The same as the MBT), musics for meditation and consists of meditation-videos of 40 minutes. We will guide patients to choose their favorite meditation videos, such as forest, seaside, lake, snow mountain, field and so on.

  • Mindfulness-based Stress ReductionBehavioural

    39 participates randomized and allocated to this group. MBT was conducted as an 8-week group intervention. Sessions typically began with formal mindfulness meditations that include breathing exercises, prolonged expiratory relaxation, body scan, and meditation. MBT was delivered by the first author, who has specialized training in mindfulness meditation.

Study groups in NCT05637736
Study groupRoleWhat they receive
Mindfulness-based Stress Reduction by Therapeutic VRExperimentalNot described
Receives: Behavioral: Mindfulness-based Stress Reduction by Therapeutic VR
mindfulness-based therapyActive comparatorNot described
Receives: Behavioral: Mindfulness-based Stress Reduction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression, anxiety, and stress scale (DASS-21)

    The questionnaire of the Chinese version of DASS-21 has a total of 21 items and measures three negative emotional experiences of depression, anxiety and stress

    Measured: up to 8 weeks

  2. The impact of COVID-19

    There is a separate questions. "Has COVID-19 affected your mood at work?"(0~10)

    Measured: up to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2022
  2. Study start1 Mar 2022
  3. Primary completion30 Nov 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
81 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05637736
Sponsor's protocol ID
NUCM22_0708
Status last verified
Nov 2022
First submitted
24 Nov 2022
Last updated
5 Dec 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-based Stress Reduction by Therapeutic VR and Mindfulness-based Stress Reduction in people with Nurse's Role and COVID-19 Pandemic, run by Nanjing University of Traditional Chinese Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression, anxiety, and stress scale (DASS-21) (time frame: up to 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in